The NPHCDA is introducing a SECOND DOSE of measles vaccine into the routine immunization (RI) programme. This intervention is primarily aimed at providing a second dose of measles vaccine to the children who are highly susceptible to measles. 
In addition,it offers an opportunity to initiate 1st dose measles vaccination for children who might have missed in their 1st year of life or failed to seroconvert & provides an opportunity to integrate other services with immunization during the 2nd year of life for the children
Measles is an acute & highly infectious disease caused by the measles virus. It is one of the leading causes of morbidity & mortality among children under years old. Globally, an estimated 246 children die each day from measles, the majority of whom are from Africa, including 🇳🇬
